Carta científico-clínica
Análisis de supervivencia, eficacia y seguridad en psoriasis moderada–grave tratada con ustekinumab. Estudio observacional de 69 pacientes en la práctica clínica habitual
An analysis of Drug Survival, Effectiveness, and Safety in Moderate to Severe Psoriasis Treated With Ustekinumab: An Observational Study of 69 Patients in Routine Clinical Practice
I. Salgüero Fernández
, M. Hospital Gil, M. Sigüenza Sanz, G. Roustan Gullón
Autor para correspondencia
Dermatología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid
Leído
5674
Vecesse ha leído el artículo
2042
Total PDF
3632
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 162 | 61 | 223 |
| 2025 5 | 106 | 29 | 135 |
| 2025 4 | 112 | 21 | 133 |
| 2025 3 | 91 | 20 | 111 |
| 2025 2 | 100 | 21 | 121 |
| 2025 1 | 68 | 38 | 106 |
| 2024 12 | 81 | 24 | 105 |
| 2024 11 | 70 | 59 | 129 |
| 2024 10 | 60 | 46 | 106 |
| 2024 9 | 56 | 49 | 105 |
| 2024 8 | 77 | 62 | 139 |
| 2024 7 | 70 | 32 | 102 |
| 2024 6 | 107 | 35 | 142 |
| 2024 5 | 64 | 26 | 90 |
| 2024 4 | 94 | 24 | 118 |
| 2024 3 | 68 | 22 | 90 |
| 2024 2 | 54 | 27 | 81 |
| 2024 1 | 61 | 29 | 90 |
| 2023 12 | 56 | 17 | 73 |
| 2023 11 | 65 | 32 | 97 |
| 2023 10 | 54 | 24 | 78 |
| 2023 9 | 65 | 30 | 95 |
| 2023 8 | 36 | 16 | 52 |
| 2023 7 | 45 | 24 | 69 |
| 2023 6 | 36 | 18 | 54 |
| 2023 5 | 58 | 22 | 80 |
| 2023 4 | 32 | 24 | 56 |
| 2023 3 | 52 | 22 | 74 |
| 2023 2 | 59 | 17 | 76 |
| 2022 1 | 37 | 30 | 67 |
| 2022 12 | 52 | 43 | 95 |
| 2022 11 | 63 | 34 | 97 |
| 2022 10 | 77 | 36 | 113 |
| 2022 9 | 51 | 46 | 97 |
| 2022 8 | 44 | 55 | 99 |
| 2022 7 | 46 | 47 | 93 |
| 2022 6 | 48 | 37 | 85 |
| 2022 5 | 53 | 80 | 133 |
| 2022 4 | 35 | 23 | 58 |
| 2022 3 | 34 | 46 | 80 |
| 2022 2 | 31 | 19 | 50 |
| 2021 1 | 33 | 41 | 74 |
| 2021 12 | 32 | 36 | 68 |
| 2021 11 | 49 | 44 | 93 |
| 2021 10 | 48 | 58 | 106 |
| 2021 9 | 27 | 39 | 66 |
| 2021 8 | 32 | 25 | 57 |
| 2021 7 | 36 | 32 | 68 |
| 2021 6 | 40 | 31 | 71 |
| 2021 5 | 37 | 39 | 76 |
| 2021 4 | 82 | 37 | 119 |
| 2021 3 | 62 | 32 | 94 |
| 2021 2 | 61 | 16 | 77 |
| 2020 1 | 54 | 18 | 72 |
| 2020 12 | 36 | 19 | 55 |
| 2020 11 | 33 | 16 | 49 |
| 2020 10 | 36 | 18 | 54 |
| 2020 9 | 20 | 16 | 36 |
| 2020 8 | 21 | 17 | 38 |
| 2020 7 | 32 | 14 | 46 |
| 2020 6 | 35 | 25 | 60 |
| 2020 5 | 27 | 9 | 36 |
| 2020 4 | 28 | 11 | 39 |
| 2020 3 | 35 | 21 | 56 |
| 2020 2 | 21 | 11 | 32 |
| 2020 1 | 2 | 0 | 2 |
| 2019 11 | 2 | 0 | 2 |
| 2019 10 | 1 | 0 | 1 |
| 2019 9 | 11 | 2 | 13 |
| 2019 8 | 0 | 4 | 4 |
| 2019 7 | 12 | 0 | 12 |
| 2019 6 | 1 | 4 | 5 |
| 2019 5 | 8 | 2 | 10 |
| 2019 4 | 37 | 23 | 60 |
| 2019 3 | 1 | 2 | 3 |
| 2019 2 | 2 | 0 | 2 |
| 2019 1 | 2 | 0 | 2 |
| 2018 12 | 2 | 4 | 6 |
| 2018 11 | 1 | 2 | 3 |
| 2018 10 | 3 | 2 | 5 |
| 2018 8 | 0 | 2 | 2 |
| 2018 7 | 0 | 3 | 3 |
Mostrar todo
